Richard E. Russell

Insider

First SEC filing: Dec. 12, 2017 · Latest: Dec. 12, 2017

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 19, 2020	NERV	A	185,025	—	—	185,025 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 31, 2019	NERV	A	49,975	—	—	49,975 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 12, 2019	NERV	S	3,113	$7.42	$23,098	33,770 Direct	-8.44%	Disposed	-92.0% (price as of 2026-08-20)
Dec. 12, 2018	NERV	S	3,117	$7.96	$24,811	36,883 Direct	-7.79%	Disposed	-92.5% (price as of 2026-08-20)
Dec. 11, 2018	NERV	A	260,000	—	—	260,000 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 11, 2017	NERV	A	775,000	—	—	775,000 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 11, 2017	NERV	A	40,000	—	—	40,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 19, 2020	NERV	Employee Stock Option (right to buy)	Common Stock (185,025)	$7.11	Dec. 31, 2029	185,025	Acquired
Dec. 31, 2019	NERV	Employee Stock Option (right to buy)	Common Stock (49,975)	$7.11	Dec. 30, 2029	49,975	Acquired
Dec. 11, 2018	NERV	Employee Stock Option (right to buy)	Common Stock (260,000)	$7.96	Dec. 10, 2028	260,000	Acquired
Dec. 11, 2017	NERV	Employee Stock option (Right to Buy)	Common Stock (775,000)	$6.05	Dec. 10, 2027	775,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).